Description
Corixa Corporation developed immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Corixa was acquired by GSK in 2005.
Team Members
Steven Gillis
Co-founder
Kennet Grabstein
Co-founder and affiliate investigator at Fred Hutchinson Cancer Research Center
Steven Reed
Co-founder and Professor of Pathobiology, University of Washingon
